BioView receives Korea FDA approval

BioView is pleased to announce the receipt of Korean FDA approval for marketing of Bioview’s scanning systems in Korea. Bioview’s cell imaging systems for analysis of cells stained by morphological, immunohistochemical and FISH markers allows automatic scanning, imaging and analysis via Bioview’s unique software. The company has a full range of imaging and offline analysis workstations, including Accord, Allegro+ and Duet-3.